Difference between revisions of "Communications Committee"
Jump to navigation
Jump to search
m (→Scope) |
m |
||
| Line 12: | Line 12: | ||
==Scope== | ==Scope== | ||
The Communications Committee supports QIBA Biomarker Committees by providing visibility to QIBA efforts. | The Communications Committee supports QIBA Biomarker Committees by providing visibility to QIBA efforts. | ||
| + | |||
| + | ==QIBA Community== | ||
| + | A QIBA Community has been set up via the Higher Logic platform on RSNA web pages to encourage continuing dialogue among QIBA members and across modalities. Instructions are available here: | ||
| + | |||
| + | * [[Media:02 09 2021 QIBA Community Instructions-101-FINAL.pdf | Quick Start Guide]] | ||
| + | * [[Media:02 09 2021 QIBA Community Instructions-201-FINAL.pdf | Detailed Community Instructions]] | ||
==Meetings/Call Summaries== | ==Meetings/Call Summaries== | ||
Revision as of 22:23, 9 February 2021
- Chairs: Anne M. Smith, PhD; Majid Chalian, MD
- RSNA Staff Support: Julie Lisiecki
Communications Committee Mission Statement
QIBA Communications will educate and publicize the impact of image quantification on therapeutic and drug clinical trials and patient disease staging and follow-up.
- Oversee educational component
Scope
The Communications Committee supports QIBA Biomarker Committees by providing visibility to QIBA efforts.
QIBA Community
A QIBA Community has been set up via the Higher Logic platform on RSNA web pages to encourage continuing dialogue among QIBA members and across modalities. Instructions are available here:
Meetings/Call Summaries
Monthly Tcons (Contact Julie for details)
Approved call summaries: